Form 4: Omeros Corp Director Diana T. Perkinson Receives Stock Option Award

Director Diana T. Perkinson receives a stock option to purchase 15,000 shares of Omeros Corp common stock as part of the company's non-employee director compensation policy.

Summary

• Diana T. Perkinson, a director at Omeros Corp, was granted a stock option to purchase 15,000 shares of common stock on June 6, 2024.
• The option was awarded as part of Omeros Corporation's non-employee director compensation policy.
• The option will fully vest and become exercisable on the day before the date of the 2025 annual meeting of shareholders, contingent upon Perkinson's continued service as a director.

Sentiment

Score: 7

Explanation: The document reflects a routine director compensation event, which is generally viewed neutrally. The grant of stock options can be seen as a positive incentive for the director.

Positives

• The stock option grant aligns the director's interests with those of the shareholders.
• The vesting schedule incentivizes continued service as a director.

Future Outlook

The director will be eligible to exercise the option contingent on continued service through the day before the 2025 annual meeting of shareholders.

Industry Context

Stock option grants are a common form of compensation for non-employee directors, aligning their interests with the long-term performance of the company.

Comparison to Industry Standards

• Director compensation packages, including stock options, vary significantly across the biotechnology industry depending on company size, stage of development, and performance.
• Comparing Omeros' director compensation to that of similar-sized biotech companies would provide a more comprehensive assessment of its competitiveness.

Stakeholder Impact

• The stock option grant could potentially increase shareholder value if the director's actions lead to improved company performance.
• The grant has no immediate impact on employees, customers, suppliers, or creditors.

Key Dates